Agnes Gasoirek

Agnes Gasoirek is a senior clinical pharmacology specialist at Novo Nordisk, where she has contributed to research on the experimental weight-loss medication amycretin, which has shown promising results in helping participants lose significant amounts of weight without plateauing.